Price dispersion of generic medications


Autoři: John J. J. Bernstein aff001;  Gerhard B. Holt aff002;  Joseph Bernstein aff003
Působiště autorů: Haverford High School, Haverford, Pennsylvania, United States of America aff001;  Independent Scholar, Philadelphia, Pennsylvania, United States of America aff002;  University of Pennsylvania, Philadelphia, Pennsylvania, United States of America aff003
Vyšlo v časopise: PLoS ONE 14(11)
Kategorie: Research Article
doi: 10.1371/journal.pone.0225280

Souhrn

Generic pharmaceuticals should have very little price dispersion. Economics’ Law of One Price suggests that identical goods, in the absence of trade frictions and under conditions of free competition and price flexibility, should sell for the same price, and the FDA ensures that generics are identical. In this study, we examine whether generic pharmaceuticals indeed have the low price dispersion that theory predicts, and if not, whether the dispersion seen for pharmaceuticals used to treat neuropsychiatric conditions is substantially higher than that of other drugs. Such a difference may offer an explanation for the price dispersion seen: namely, a strategy that takes advantage of buyers’ cognitive constraints and impaired ability to comparison shop. We thus assembled a list of generic pharmaceuticals and their prices using www.GoodRx.com, based on a convenience sample of the 5 most popular drugs for 10 common medical conditions listed there. Three neuropsychiatric diagnoses were used: Alzheimer's disease, depression and schizophrenia. Seven other diagnoses served as controls: asthma; diabetes mellitus-type II; high cholesterol; hypertension; osteoarthritis; osteoporosis; and urinary tract infection. For each drug, we identified the highest and lowest prices and calculated the mean, median and coefficient of variation (CV). We further calculated the ratios of the highest price to the median price and of the highest to lowest price. We found that the mean price CV was 43%. For neuropsychiatric drugs and controls, it was 61% and 35%, respectively. The mean high-to-median ratio was3.7 for neuropsychiatric drugs and 1.9 for controls. The mean high-to-low ratio was 5.9 for neuropsychiatric drugs and 2.8 for controls. In short, generic medications have high price dispersion, despite public availability of prices. Although our study did not examine why this price dispersion is present, the especially large high-to-low price ratio for neuropsychiatric medications suggests a strategy that exploits vulnerable patients.

Klíčová slova:

Asthma – Drugs – Hypercholesterolemia – Hypertension – Osteoarthritis – Schizophrenia – Urinary tract infections


Zdroje

1. Miller D. You paid how much for that medicine?. Clinical Psychiatry News 2019; https://www.mdedge.com/psychiatry/article/156908/business-medicine/you-paid-how-much-medicine [visited April 27, 2019].

2. Scholten P, Smith AS. Price dispersion then and now: Evidence from retail and e-tail markets. The Economics of the Internet and E-commerce:63–88.

3. Sorensen AT. Equilibrium Price Dispersion in Retail Markets for Prescription Drugs. Journal of Political Economy. 2000;108(4):833–850.

4. Ellison G, Ellison SF. Search, Obfuscation, and Price Elasticities on the Internet. Econometrica. 2009;77(2):427–452.

5. Dobkin HE, Zirwas M. Price discrepancies among mobile medication applications for common dermatologic prescriptions: Observational cost analysis. Journal of the American Academy of Dermatology. Dec 2017;77(6):1181–1182. doi: 10.1016/j.jaad.2017.07.017 29132854


Článek vyšel v časopise

PLOS One


2019 Číslo 11